Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 2 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1

Interventions

Metformin 7 Surveys and Questionnaires 3 Nutrition Assessment 3 Exercise 3 Tirzepatide 2 Therapeutics 2 Tablets 2 Standard of Care 2 Specimen Handling 2 Resistance Training 2 Methods 2 Interviews as Topic 2 Glucose Tolerance Test 2 Educational Status 2 Biopsy 2 tocilizumab 1 tislelizumab 1 pembrolizumab 1 epalrestat 1 donafenib 1 amlodipine, atorvastatin drug combination 1 Verapamil 1 Urine Specimen Collection 1 Testosterone 1 Secretin 1 Second Harmonic Generation Microscopy 1 Risk Assessment 1 Remote Consultation 1 Preventive Health Services 1 Practice Guidelines as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Diabetes Mellitus × Hypoglycemic Agents × Clear all

NCT06100796 2023-10-25

NSCLC

Assiut University

Diabetes Mellitus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡